Form D · Other Health Care
NeuroRecovery Technologies, Inc.
Dana Point, CA · CIK 0001691713
Offering snapshot reported Dec 7, 2016 · SEC filing
- Reported sold
- $3.04M Offering amount: $6.25M
- Investors reported
- 9 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 23, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 7, 2016 | Initial | $3,037,526 | No comparison | 9 | SEC filing |
Offering details
- Securities
- Equity, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-275805
Source: Form D, filed Dec 7, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Joel Burdick | Director |
| V. Reggie Edgerton | Director, Executive |
| John Fischer | Executive |
| Bradley R. Langdale | Director |
| Jay Shepard | Director |
| Nicholas A. Terrafranca | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
32932 Pacific Coast Highway Suite #14 182
Dana Point, CA, 92629
Dana Point, CA, 92629